Happify Health
51 E 12th St Fl 5, New York, NY, 10003, United States
Overview
Happify Health is a software-enabled healthcare platform focused on improving mental and physical health through evidence-based, scientifically validated programs. The company offers two core solutions—Digital Therapeutics and Care Delivery—serving enterprises, health plans, health systems, pharmaceutical manufacturers and individuals. Its platform includes telehealth, AI-powered coaching and access to therapeutics, and supports more than 10 chronic conditions in 10 languages, covering over 20 million lives. Led by Co-Founder and CEO Tomer Ben-Kiki and President and Co-Founder Ofer Leidner, Happify emphasizes behaviorally-driven interventions and configurable digital therapeutics. The company plans to use new capital to expand its Digital Therapeutics and Care Delivery offerings and pursue global business development opportunities. It also intends to invest further in AI and machine-learning models that power Anna, its software-based coach for chronic conditions, especially mental health. Happify Health provides a digital intervention platform combining evidence-based interventions (CBT, positive psychology, mindfulness, neuroscience) with engagement strategies and gamification. The platform offers more than 60 programs and over 2,500 activities accessible via web and mobile apps. It delivers configurable solutions for individuals, health plans, employers and care delivery systems, addressing resilience, stress, depression, anxiety, chronic pain, insomnia and social isolation. Happify works with partners and clients to integrate screening, delivery, ongoing maintenance and support, and has partnerships with major health insurers and Fortune 500 employers, including a collaboration with Humana. The company plans to use new capital to increase infrastructure support, continue research in real-world interventions, and enhance and expand the Happify platform to accelerate adoption in healthcare and enterprise settings.
- Total raised
- $82M
- Funding rounds
- 2
- Latest round
- Series D
- Latest activity
- Mar 2021
Industries
- Health Care
Recent funding
Series D
Mar 2021
$73M
Equity
Aug 2017
$9M